A recent study determined the lifetime risk of developing dementia is double that of previous estimates. But there’s good ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

Researchers analyzed the brain of a woman with down syndrome and Alzheimer’s disease, and were shocked to discover that ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Discover how Alzheimer's disease progresses from mild cognitive changes to severe symptoms, with explanations of each stage ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...

But the shingles studies published in 2024, along with a host of new papers, add weight to an alternative decades-old ...

Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.

Genetic testing can detect whether someone has APOE-e4, but having one or two copies of e4 cannot predict the development of ...

Their risk of getting it increases with each decade after 40, and their overall lifetime risk is more than 90%.

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...